PavaniChalasaniMDMPH

Breast Cancer

Director, Division of Hematology-Oncology Medical Director, Inpatient Oncology Services Co-Lead, Clinical and Translational Oncology Program George Washington Cancer Center George Washington University

Request Appointment

Overview of Dr. Chalasani

Dr. Pavani Chalasani is an oncologist in Washington, DC and is affiliated with multiple hospitals in the area, including George Washington University Hospital and Banner - University Medical Center Tucson. She received her medical degree from Gandhi Medical College and has been in practice 15 years. Dr. Chalasani accepts several types of health insurance, listed below. She is one of 40 doctors at Banner - University Medical Center Tucson and one of 37 doctors at George Washington University Hospital who specialize in Oncology. She has more than 50 publications and over 500 citings.

Office
2150 Pennsylvania Ave NW
Washington, DC 20037
Book by Phone+1(954) 914-7021
Is this information wrong?

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 2006 - 2009
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 2004 - 2005
Gandhi Medical CollegeClass of 2002

Certifications & Licensure

DC State Medical License 2023 - 2024
AZ State Medical License 2009 - 2024
IL State Medical License 2004 - 2007
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer Start of enrollment: 2014 Jan 08
Completed
Phase 2
Estradiol Levels in Patients Treated With Estring Start of enrollment: 2013 Aug 09
Completed
Phase 2
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN) Start of enrollment: 2017 Aug 11
Completed
Not Applicable
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer Start of enrollment: 2018 Dec 06
Completed
Phase 2
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets Start of enrollment: 2018 Dec 19
Completed
Early Phase 1
Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome Start of enrollment: 2018 Feb 28
Completed
Not Applicable
Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors Start of enrollment: 2019 Apr 19
Active, not recruiting
Early Phase 1
Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women Start of enrollment: 2022 Aug 30
Withdrawn
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia Start of enrollment: 2020 Apr 27
Completed
Early Phase 1
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) Start of enrollment: 2018 Jun 27
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery Start of enrollment: 2020 Feb 20
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Novel Thermal Imaging Technique for Breast Screening Start of enrollment: 2022 Nov 15
Suspended
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Predictors of persistence of post-chemotherapy symptoms among survivors of solid tumor cancers.
Alla Sikorskii, Terry Badger, Chris Segrin, Tracy E Crane, Nathan Cunicelli, Pavani Chalasani, Waqas Arslan, Charles Given> ;Quality of Life Research. 2024 Apr 1
Transcranial Magnetic Stimulation for the Treatment of Chemo Brain.
Phillip H Kuo, Allison Yu-Chin Chen, Rudolph J Rodriguez, Carol Stuehm, Pavani Chalasani, Nan-Kuei Chen, Ying-Hui Chou> ;Sensors. 2023 Sep 22
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William Gradishar, Sagar Sardesai, Jason ...> ;Nature Communications. 2023 Aug 7
5 citations
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi, Zahi Mitri, Carlo Palmieri, Linnea I Chap, Paul Richards, William Gradishar, Sagar Sardesai, Jason ...> ;Nature Communications. 2023 Jul 24
6 citations
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study.
Funda Meric-Bernstam, Emiliano Calvo, Keun Seok Lee, Victor Moreno, Yeon Hee Park, Sun Young Rha, Pavani Chalasani, Wei Zhong, Li Zhou, Steven Pirie-Shepherd, Abraham ...> ;Molecular Cancer Therapeutics. 2023 Oct 2
1 citations
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.
Elena Shagisultanova, William Gradishar, Pavani Chalasani, Andrew J Brenner, Alison Stopeck, Hannah Parris, Dexiang Gao, Jose Mayordomo, Peter Kabos, Virginia F Borges...> ;Clinical Cancer Research. 2023 Dec 15
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients.
Jessica A Martinez, Betsy C Wertheim, Denise J Roe, Mihra S Taljanovic, H-H Sherry Chow, Wade Chew, Sima Ehsani, Sao Jiralerspong, Jennifer Segar, Pavani Chalasani> ;Metabolites. 2023 Mar 20
1 citations
A Sequential Multiple Assignment Randomized Trial of Symptom Management After Chemotherapy.
Alla Sikorskii, Terry Badger, Chris Segrin, Tracy E Crane, Pavani Chalasani, Waqas Arslan, Mary Hadeed, Kristin E Morrill, Charles Given> ;Journal of Pain and Symptom Management. 2023 Jun 1
Nuclear epidermal growth factor receptor as a therapeutic target.
Benjamin Atwell, Pavani Chalasani, Joyce Schroeder> ;Exploration of Targeted Anti-Tumor Therapy. 2023 Jan 1
3 citations
Social Determinants of Health and Symptom Burden During Cancer Treatment.
Terry A Badger, Chris Segrin, Tracy E Crane, Pavani Chalasani, Waqas Arslan, Mary Hadeed, Alla Sikorskii> ;Nursing Research. 2022 Dec 9
4 citations
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer Immunochemotherapy.
Zhiren Wang, Leyla Estrella Cordova, Pavani Chalasani, Jianqin Lu> ;Molecular Pharmaceutics. 2022 Dec 5
2 citations
Use of scheduled and unscheduled health services by cancer survivors and their caregivers.
Alla Sikorskii, Chris Segrin, Tracy E Crane, Pavani Chalasani, Waqas Arslan, Jessica Rainbow, Mary Hadeed, Charles Given, Terry A Badger> ;Supportive Care in Cancer. 2022 Sep 1
2 citations
Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias.
Jessica A Martinez, Mihra S Taljanovic, Andres A Nuncio Zuniga, Betsy C Wertheim, Denise J Roe, Sima Ehsani, Sao Jiralerspong, Jennifer Segar, Pavani Chalasani> ;Journal of Clinical Medicine. 2022 Feb 18
3 citations
Sulindac Improves Stiffness and Quality of Life in Women Taking Aromatase Inhibitors for Breast Cancer.
Jessica A Martinez, Betsy C Wertheim, Denise J Roe, Pavani Chalasani, Jules Cohen, Lea Baer, H-H Sherry Chow, Alison T Stopeck, Patricia A Thompson> ;Breast Cancer Research and Treatment. 2022 Feb 1
144 citations
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jerg...> ;Nature Medicine. 2021 Sep 30
9 citations
A randomized controlled trial of metformin in women with components of metabolic syndrome: intervention feasibility and effects on adiposity and breast density.
Edgar Tapia, Diana Evelyn Villa-Guillen, Pavani Chalasani, Sara M. Centuori, Denise J. Roe, Jose M. Guillen-Rodriguez, Chuan Huang, Jean-Phillippe Galons, Cynthia A. T...> ;Breast Cancer Research and Treatment. 2021 Aug 12
8 citations
Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors.
Patricia A Thompson, Chuan Huang, Jie Yang, Betsy C. Wertheim, Denise J. Roe, Xiaoyue Zhang, Jie Ding, Pavani Chalasani, Christina Preece, Jessica A. Martinez, H-H. Sh...> ;Clinical Cancer Research. 2021 Jun 10
5 citations
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide P...
Lynn Symonds, Isaac C. Jenkins, Hannah M. Linden, Brenda F. Kurland, Julie Gralow, Vijayakrishna V K Gadi, Georgiana K. Ellis, Qian Wu, Eve T. Rodler, Pavani Chalasani...> ;Clinical Breast Cancer. 2021 May 24
25 citations
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jerg...> ;Medrxiv. 2021 May 14
10 citations
Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study
Mark T. Reding, Ingrid Pabinger, Pål Andre Holme, Lone Hvitfeldt Poulsen, Claude Negrier, Pavani Chalasani, Monika Maas Enriquez, Maria Wang, Karina Meijer, Maria Elis...> ;Haemophilia. 2021 Apr 5
3 citations
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer
Pavani Chalasani, Kiah J. Farr, Vicky Wu, Isaac C. Jenkins, Alex Liu, Stephanie Parker, Vijayakrishna K. Gadi, Jennifer M. Specht, Hannah M. Linden> ;Breast Cancer Research and Treatment. 2021 Apr 2
3 citations
Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor-induced joint pain: a pilot study.
Jessica A. Martinez, Mihra S. Taljanovic, Russell S. Witte, Andres A. Nuncio Zuniga, Betsy C. Wertheim, C. Kent Kwoh, Brian A. Goldstein, Denise J. Roe, Pavani Chalasani> ;Journal of Ultrasonography. 2021 Mar 8
7 citations
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors
Alyssa Streff, Michele Chu-Pilli, Alison Stopeck, Pavani Chalasani> ;Supportive Care in Cancer. 2021 Jan 1
4 citations
Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma.
Jennifer Segar, Ritu Pandey, Kiah J. Farr, Raymond B. Nagle, Lauren LeBeau, Victor J. Gonzalez, Pavani Chalasani> ;International Journal of Breast Cancer. 2020 Nov 22
2 citations
Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy
Pavani Chalasani, Mihra S. Taljanovic, Jenn Segar, Kiah J. Farr, Hninyee Win, Betsy C. Wertheim, Michele Chu-Pilli, Sima Ehsani, Denise J. Roe, Lana H. Gimber> ;Breast Cancer Research and Treatment. 2020 Aug 28
Join now to see all

Press Mentions

Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast CancerMay 2nd, 2023
Finding Better Paths to Treat Pain and Prevent AddictionApril 21st, 2022
UA Researchers Study Immunity Against New Coronavirus VariantsFebruary 24th, 2021
Join now to see all

Hospital Affiliations

George Washington University HospitalWashington, District of Columbia
Banner - University Medical Center TucsonTucson, Arizona

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Health Net Arizona PPO/POS
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref
Please verify your coverage with the provider's office directly when scheduling an appointment